Details for 2019218071
Up to date per 06.04.2026
Actions
Details for 2019218071
Granted/Registered
European Patent
05.08.2020 A
05.06.2024 B1
14.04.2015
US
201562147427 P
A61K 31/277 20060101AFI20231102BHEP
Owner
Milestone Pharmaceuticals Inc.1111 Dr. Frederik-Philips Boulevard Suite 420 Saint-Laurent, Québec H4M 2X6CA
Representative
No representatives present
Inventor
MAGUIRE, Martin P.70 US Oval, Apt. 413 Plattsburg, NY 12903US
Information about Fees